[1]
2020. Osteoprotegerin, C- Reactive protein and Fibroblast Growth Factor-23 in Stage (II-IV) CKD Patients and Their potential for Increased incidence of Cardiovascular Disorders. Indian Journal of Public Health Research & Development. 11, 8 (Aug. 2020), 206–213. DOI:https://doi.org/10.37506/ijphrd.v11i8.10923.